Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F57GW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $93,929
Award facts
- Contract value 100% obligated
- $93,929.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 12, 2026, for the supply of Xarelto 20 mg tablets in quantities of 90 units. This firm fixed-price delivery order carries a ceiling value of $93,929.20 with an ultimate completion date of January 13, 2026, and represents a non-competitive award through an existing indefinite delivery contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. The award supports the federal government's pharmaceutical procurement requirements for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026. AmerisourceBergen's substantial IDC portfolio with the Defense Logistics Agency underscores its critical role as a preferred pharmaceutical distributor for federal medical supply chains. The company's federal contract history demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, making it a qualified vendor for supporting military healthcare programs and defense-related medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F57GW?
SPE2DR26F57GW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F57GW worth?
The government has obligated $93,929 on SPE2DR26F57GW.
Is contract SPE2DR26F57GW an order under another contract?
Yes. SPE2DR26F57GW is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57GW competed?
The extent of competition for SPE2DR26F57GW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award